Evidence map›Paper›PMID 40587062›Full record

ArticleCEN case reports2025

Early low-density lipoprotein apheresis for steroid-resistant minimal change disease with acute kidney injury: a case report.

Miya Hiramatsu, Masatoshi Inoue, Naoki Kamegai, Ohno Michiya, Junichiro Yamamoto

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miya HiramatsuDepartment of Nephrology, Asahi University Hospital, 3-23 Hashimoto-cho, Gifu, Gifu, 500-8523, Japan.
Masatoshi InoueDepartment of Nephrology, Asahi University Hospital, 3-23 Hashimoto-cho, Gifu, Gifu, 500-8523, Japan. inoue.masatoshi333@gmail.com.ORCID 0000-0002-3024-0422
Naoki KamegaiDepartment of Nephrology, Asahi University Hospital, 3-23 Hashimoto-cho, Gifu, Gifu, 500-8523, Japan.
Ohno MichiyaDepartment of Nephrology, Asahi University Hospital, 3-23 Hashimoto-cho, Gifu, Gifu, 500-8523, Japan.
Junichiro YamamotoDepartment of Nephrology, Asahi University Hospital, 3-23 Hashimoto-cho, Gifu, Gifu, 500-8523, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 75-year-old woman with steroid-resistant minimal change disease (MCD) whose refractory proteinuria and hypoproteinemia were controlled with early low-density lipoprotein apheresis (LDL-A). She was initially treated with steroid therapy, including methylprednisolone pulse. However, her hypoproteinemia, severe proteinuria, accompanied with renal insufficiency persisted despite these therapies. We initiated hemodialysis on day 17, and LDL-A on day 18. After the treatment, we found an improvement in her urine protein excretion, hyperlipidemia, and hypoproteinemia gradually. Her renal function returned to normal. We added cyclosporine A (CyA) after confirming the normal renal function. Her proteinuria was 0.693 g/day on day 350 and she achieved incomplete remission type I. There are few reports of the efficacy of LDL-A in older patients with MCD with acute kidney injury (AKI). In addition, there are only a few reports of cases in which LDL-A was introduced early, as in this case. This case suggests that early LDL-A may be an effective therapy for steroid-resistant MCD with AKI.

Indexed as

Acute Kidney InjuryBlood Component RemovalLipoproteins, LDLNephrosis, LipoidAgedCyclosporineDrug ResistanceFemaleHumansHypoproteinemiaMethylprednisoloneProteinuriaRenal DialysisTreatment OutcomeCyclosporineLipoproteins, LDLMethylprednisoloneAcute kidney injuryHemodialysisLow-density lipoprotein apheresisMinimal change diseaseNephrotic syndrome

Identifiers

PMID40587062
PMCPMC12457249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.